Partner news 18 May 2021 Mestag Therapeutics announces collaboration with Janssen, focused on the discovery of novel fibroblast targets for the treatment of inflammatory disease Read full story
Partner news 15 May 2019 TU Dresden announces collaboration with Janssen to advance next-generation nuclease-free gene editing platform Read full story